In this casefocused textbased activity experts discuss key factors in selecting treatment for patients with relapsedrefractory chronic lymphocytic leukemia
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/hematology/individualizing-2l-cll-therapy-1/20158-50963
- Start Date: 2024-09-16 05:00:00
- End Date: 2024-09-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: AbbVie (Any division) - Amount: 50000.0 - Is Kind Support: False Source: AstraZeneca (Any division) - Amount: 62500.0 - Is Kind Support: False Source: Beigene - Amount: 50000.0 - Is Kind Support: False Source: Bristol-Myers Squibb Company - Amount: 25000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest